Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

A case of autoimmune hepatitis with Graves' disease treated by propylthiouracil.

Sato I, Tsunekawa T, Shinohara Y, Nishio Y, Shimizu Y, Suzuki Y, Yoshioka S.

Nagoya J Med Sci. 2011 Aug;73(3-4):205-9.

2.

[Asymptomatic hepatitis induced by propylthiouracil].

De Castro JJ, Nobre EL, Garcia e Costa J, Galv√£o-Teles A.

Acta Med Port. 2001 Sep-Dec;14(5-6):523-7. Review. Portuguese.

3.

The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.

Kimura M, Seki T, Ozawa H, Ishihara T, Komatsu M, Tajiri S, Yanagi H, Nishina M, Noh JY, Fukagawa M, Takagi A.

Endocr J. 2013;60(3):383-8. Epub 2012 Nov 16.

4.

Propylthiouracil-induced severe hepatitis: a case report and review of the literature.

Ichiki Y, Akahoshi M, Yamashita N, Morita C, Maruyama T, Horiuchi T, Hayashida K, Ishibashi H, Niho Y.

J Gastroenterol. 1998 Oct;33(5):747-50. Review.

PMID:
9773944
6.

The propylthiouracil dilemma.

Glinoer D, Cooper DS.

Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):402-7. doi: 10.1097/MED.0b013e3283565b49. Review.

PMID:
22820213
7.

Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.

He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.

Clin Endocrinol (Oxf). 2004 Jun;60(6):676-81.

PMID:
15163329
8.
9.

Severe hepatotoxicity on beginning propylthiouracil therapy.

Lock DR, Sthoeger ZM.

J Clin Gastroenterol. 1997 Jun;24(4):267-9.

PMID:
9252857
10.

Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease.

Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A, Hamada N.

J Clin Endocrinol Metab. 2007 Jun;92(6):2157-62. Epub 2007 Mar 27.

PMID:
17389704
11.

Propylthiouracil-associated liver failure presenting as probable autoimmune hepatitis in a child with Graves' disease.

Sipe WE, Su M, Posselt A, Kim GE, Quiros JA, Rosenthal P.

Pediatr Transplant. 2006 Jun;10(4):525-8.

PMID:
16712616
12.

Propylthiouracil hepatitis: report of a case and extensive review of the literature.

Memi E, Karras S, Tzotzas T, Krassas GE.

J Pediatr Endocrinol Metab. 2012;25(3-4):331-43. Review.

PMID:
22768665
13.

Antineutrophilic cytoplasmic antibody-positive systemic vasculitis associated with propylthiouracil therapy: report of 2 children with Graves' disease.

Poomthavorn P, Mahachoklertwattana P, Tapaneya-Olarn W, Chuansumrit A, Chunharas A.

J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1295-301.

PMID:
12549809
14.

[Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].

Komaki T, Sakata S, Nakamura S, Matsuda M, Kojima N, Takuno H, Miura K.

Nihon Naibunpi Gakkai Zasshi. 1989 Jul 20;65(7):627-39. Japanese.

PMID:
2583311
16.

Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves' disease.

Sera N, Ashizawa K, Ando T, Abe Y, Ide A, Usa T, Tominaga T, Ejima E, Yokoyama N, Eguchi K.

Thyroid. 2000 Jul;10(7):595-9.

PMID:
10958312
17.

Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism.

Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A.

Clin Endocrinol (Oxf). 2001 Mar;54(3):385-90.

PMID:
11298092
18.
20.

Analysis of 90 cases of antithyroid drug-induced severe hepatotoxicity over 13 years in China.

Yang J, Li LF, Xu Q, Zhang J, Weng WW, Zhu YJ, Dong MJ.

Thyroid. 2015 Mar;25(3):278-83. doi: 10.1089/thy.2014.0350. Epub 2014 Dec 11.

PMID:
25384184

Supplemental Content

Support Center